Companies /Healthcare

Cardinal Health Inc

NYSE: CAH Medical Distribution
$271.95
▲ $4.13 (+1.54%) today
Markets closed · 6:15pm ET

24/7 Wall St. View

Price Prediction $321.61 +20.1% Our analysts’ 12-month view: target, optimistic case, and floor. CAH price prediction → Earnings Beat +10.9% EPS vs. the estimate, revenue, and how the market reacted. CAH earnings history →

CAH at a Glance

Valuation
Market cap
$62.0B
P/E ratio
36.2
Profitability
Revenue (TTM)
$254.2B
Profit margin
0.7%
EPS (TTM)
$7.39
Price
52-week range
$180 – $286
24/7 target
$321.61
Street target
$274.87
Earnings
Next report
Feb 3, 2027
Q1 2027 EPS
$3.26
vs. $2.94 est.
+10.9%

Headquartered in Dublin, OH Fiscal year ends June NYSE: CAH cardinalhealth.com

About Cardinal Health

Cardinal Health is a healthcare services and products company. Its largest business distributes branded, specialty and generic pharmaceuticals.

**Pharmaceutical and Specialty Solutions** is by far its largest segment, generating most of revenue. It serves retail pharmacy chains such as CVS Health, with which it recently signed a binding letter of intent to renew distribution agreements. It also serves hospitals and specialty and physician practices, and operates a generics sourcing program.

**Global Medical Products and Distribution** manufactures and distributes medical and laboratory products, including the Cardinal Health Brand line. The company is running an ongoing improvement plan for this segment.

**Other** consists of three operating segments:
- **Nuclear and Precision Health Solutions:** nuclear pharmacies and manufacturing facilities.
- **at-Home Solutions:** home-health and direct-to-patient products and services. The company is expanding this business through the pending acquisition of AdaptHealth's Diabetes Health business.
- **OptiFreight Logistics:** logistics and freight management.

The company also provides performance and data solutions, including real-world evidence research with pharmaceutical partners such as Eli Lilly. Updated

Revenue by Segment · Q1 2027
  1. Pharmaceutical and Specialty Solutions93%
  2. Global Medical Products and Distribution5%
  3. Other3%

Latest Activity

Biggest movers · On the open
Gainers
  • APPAppLovin$351.85+29.5%
  • VERXVertex$18.06+13.4%
  • TMToyota$218.6+9.6%
  • SONYSony Group$28.18+8.7%
  • CAHCardinal Health$283.59+8.2%
Losers
  • BROSDutch Bros$37.27-15.1%
  • MELIMercadoLibre$1,537.88-11.6%
  • BEBloom Energy$177.57-11.4%
  • ASXASE Technology Holding$33.24-11.3%
  • CAVACava$55.22-10.6%

AppLovin opened up 29.5%, the single biggest move across 382 priority names and nearly double the next gainer. The downside is just as wide, with Dutch Bros off 15.1% and four more names down double digits.

Read more
CAHCardinal Health
Q1 2027
EPS
$3.26
est $2.94+10.9%
Revenue
$67.51B
est $66.51B+1.5%

Full-year guidance went up to $12.80 to $13.00 per share, and management locked in a binding letter of intent to renew its CVS Health distribution agreements, removing the biggest customer-concentration question hanging over the stock. Pharmaceutical and Specialty Solutions profit rose 17%, the fourth straight quarter of beating EPS expectations.

Quarterly EPS — reported vs estimate
Read more
Earnings · 2027 Q1Jason M. HollarChief Executive Officer, Cardinal Health
Given this quarter's strong performance and our updated expectations for the remainder of the year, we are raising our fiscal 2027 non-GAAP EPS outlook.

A guidance raise one quarter into fiscal 2027 sets a higher bar for the rest of the year at the $60.7 billion distributor, and it puts pressure on rival wholesalers reporting into the same demand backdrop. Watch how much of the raise management attributes to the quarter versus the back half.

Read more
CAHCardinal Health
New 52-week high$262.01+1.7% vs prior high · 2026-10-20

Cardinal Health cleared $262.01, a fresh 52-week high, 1.73% above the peak it set on October 20. The drug distributor keeps grinding to new records.

Read more
CAHCardinal Health
New 52-week high$253.71+2.0% vs prior high · 2026-09-03

Cardinal Health closed at $253.71, a record that clears its early September peak by 2.05% and caps a climb from $154.58 a year ago. The $58.7 billion distributor has now taken out every high set during its spring stall.

Read more
CAHCardinal Health
Regular session
$241.19
+4.00%open $231.90

A 4% intraday climb to $241.19 adds roughly $2.2 billion to Cardinal Health's $55.8 billion market value, a sizable single session for a low-drama drug distributor. Whether it holds into the close is the thing to watch.

Read more

CAH Coverage

11:45am ET
Investing

Why Cardinal Health May Be a Best Buy for the Coming Stagflation

This morning’s jobs report landed hard. Nonfarm payrolls plunged by 92,000 jobs, shattering expectations of a 55,000 gain. Unemployment climbed to 4.4%, while average hourly earnings jumped 0.4% month-over-month — well above…

CAH
Rich Duprey
Load More

Frequently Asked Questions

What does Cardinal Health do?

Cardinal Health is a healthcare services and products company. Its largest business distributes branded, specialty and generic pharmaceuticals. **Pharmaceutical and Specialty Solutions** is by far its largest segment, generating most of revenue.

What is the CAH stock price target?

24/7 Wall St.'s 12-month price target for CAH is $321.61, rated Buy. The Wall Street consensus target is $274.87. CAH price prediction →